Download MBBS Venereology and Leprosy Presentations 5 Urticaria and Angioedema Lecture Notes

Download MBBS (Bachelor of Medicine, Bachelor of Surgery) 1st Year, 2nd Year, 3rd Year and Final year Venereology and Leprosy 5 Urticaria and Angioedema PPT-Powerpoint Presentations and lecture notes




URTICARIA

&

ANGIOEDEMA

? Urticaria is characterized by transient skin or mucosal

swellings due to plasma leakage.

? Superficial dermal swellings are wheals
? Deep swellings of the skin or mucosa are angioedema


WHEALS

? Pruritic, pink/ red/pale

swellings of the superficial

dermis

? ? Initial flare
? Few millimeters to several

centimeters

? Number: few to numerous.
? Hallmark : individual lesions

come and go rapidly, by

definition, in general within 24

hours.

ANGIOEDEMA

? Swellings occur deeper in the

dermis/subcutaneous/submucosal

tissue.

? May affect the mouth rarely, the

bowel.

? Involved areas : normal or faint

pink in color, rather than red

? Painful rather than itchy,
? Larger and less well defined than

wheals

? Often last for 2 to 3 days


1. Classic immediate

hypersensitivity binding of

receptor-bound specific IgE by

allergen.
? Others: stimuli that act through

the IgE receptor

2. anti-IgE and
3. anti-FcRI antibodies
4. Non-immunologic stimuli:
opiates, C5a anaphylatoxin, stem

cell factor,some neuropeptides(e.g.

substance P)
? cause mast cell degranulation by

binding specific receptors,

independent of the FcRI


PATHOGENESIS

? The mast cell is the primary effector cell of urticaria.
? Degranulation:
1. Cross-linking of two or more adjacent FcRI on the mast cell

membrane

2. initiate a chain of calcium- and energy-dependent steps
3. fusion of storage granules with the cell membrane and

externalization of their contents.
PATHOGENESIS

? Basic pathology - capillary permeability, allowing proteins and

fluids to extravasate to the dermis.

1. Histamine and other proinflammatory mediators released on

degranulation ?

Bind receptors on postcapillary venules in the skin ?
Vasodilation and increased permeability to large plasma proteins

(albumin and immunoglobulins).
2. Histamine, TNF- and IL-8 upregulate adhesion molecules on

endothelial cells, promoting the migration of inflammatory cells

into the urticarial lesion.

CLINICAL CLASSIFICATION OF

URTICARIA AND ANGIOEDEMA

1. "Ordinary" (spontaneous) urticaria
2. Physical (inducible) urticarias
3. Urticarial vasculitis (vasculitis on skin biopsy)
4. Contact urticaria (induced by percutaneous or

mucosal penetration)

5. Angioedema without wheals
6. Distinctive urticarial syndromes


ACUTE vs CHRONIC URTICARIA

? All urticarias are acute initially
? "Chronic urticaria": usually defined as 6 weeks or more.

Applied to continuous urticaria occurring at least twice

a week off treatment for 6 weeks

? Urticaria occurring 6 weeks is called episodic / recurrent


ASSOCIATIONS OF CHRONIC URTICARIA

? Autoimmune thyroid disorders
? Vitiligo
? Insulin dependent diabetes
? Rheumatoid arthritis
? Pernicious anemia
? Helicobacter pylori gastritis
? Intestinal strongyloidiasis(endemic countries)
? ???Dental infections or gastrointestinal candidiasis




CLASSIFICATION OF PHYSICAL

URTICARIA

CLASSIFICATION OF PHYSICAL

URTICARIA


CLASSIFICATION OF PHYSICAL

URTICARIA

URTICARIAL VASCULITIS

1. Favors middle-aged women
2. Urticarial lesions >24 hours in duration;

painful & burning sensation as well as

pruritus;

3. Residual purpura as they resolve
4. Sites: often occur at pressure points
5. Concurrent angioedema :up to 40% of pts
6. Disease course: average of 3 years
EXTRACUTANEOUS MANIFESTATIONS

OF URTICARIAL VASCULITIS

1. Arthralgias (50%) ? transient, migratory
2. GI (20%) ? abdominal pain, nausea, vomiting, diarrhea
3. Pulmonary obstructive disease (20%)
4. Renal (5?10%) ? proteinuria, hematuria
5. Ocular (unusual) ? conjunctivitis, episcleritis, uveitis
6. Others - Raynaud's phenomenon, livedo reticularis, splenomegaly,
lymphadenopathy, idiopathic intracranial HTN, pericardial or

muscle involvement

ASSOCIATED DISORDERS OF

URTICARIAL VASCULITIS

? Systemic lupus erythematosus
? Sj?gren's syndrome
? Serum sickness
? Cryoglobulinemia
? Infections ? hepatitis B or C virus, Epstein-Barr virus
? Rarely, solar or cold urticaria, drugs, hypergammaglobulinemia
CONTACT URTICARIA

? Development of urticaria at the site(s) of contact of urticant

with skin or mucosa

? Percutaneous or mucosal penetration of the urticant may have

distant effects, including acute urticaria or even anaphylaxis

? Immunologic and non-immunologic forms are recognized

CONTACT URTICARIA

? Immunologic: sensitized to environmental allergens (grass, animals

and foods) or in glove-wearers (latex).

? Non immunologic:

? Percutaneous microinjection of vasomediators

(histamine,acetylcholine, serotonin) via nettle stings

? contact with histamine liberators that degranulate mast cells

(dimethylsulfoxide,cobalt chloride)
FOOD CONTACT

HYPERSENSITIVITY SYNDROME

? Itching and mild swelling of the mouth, tongue

and soft palate within minutes of eating fresh

fruits but not cooked fruit

? apples, pears, peaches and cherries,

DIAGNOSIS

? Comprehensive history
? Duration of individual lesions, presence of purpura
? Weals lasting more than 24?48 h, particularly if

painful or tender, suggest urticarial vasculitis

? Frequency of attacks, duration of disease, previous

treatment, known triggers

? Past and family history,
? Occupation and leisure activities,


DIAGNOSIS

? Assessment of the impact of the disease on the patient's

quality of life.

? Asso. angiooedema (eg. Oropharynx result in difficulty in

swallowing or breathing)

? Systemic symptoms
? Recent acute infection, drugs, nonprescription and

prescription medicines, food
INVESTIGATIONS

? Rule out Infections
? Complete blood count
? Stool for ova, cysts and parasites
? Thyroid autoab, Thyroid function tests
? C4 complement (angiooedema without weals)
? Nonorgan specific autoantibodies (eg ANA)
? Basophil histamine release assay / basophil activation tests
? Helicobacter pylori (stool antigen or urea breath test)
? Chest Xray
? 25hydroxycholecalciferol (vitamin D)

TREATMENT

? Detection and avoidance of the cause.
? First line therapies (H1 antihistamines)

minimal dosing which control episodes.



H1 ? non sedating day time, sedating at night.



A combination of an H1 antihistamine with
an H2 antagonist may be more effective than

H1 antihistamines alone in some patients




TREATMENT

Second line therapies (targeted therapy)
? Oral corticosteroids
? Leukotriene receptor antagonists
? Doxepin,
? Danazol
? Sulphasalazine and dapsone


THANK YOU

This post was last modified on 08 April 2022